{"issuance_frequency":"","notes_translated":{"fr":"Le présent avis a pour but d’informer les intervenants que Santé Canada propose de : maintenir les assouplissements et la surveillance réglementaire prévus par l’Arrêté d’urgence sur les essais cliniques d’instruments médicaux et de drogues en lien avec la COVID-19 au moins jusqu’à la fin de l’automne 2021, et mettre en œuvre des modifications réglementaires qui permettraient de maintenir les assouplissements prévus par l’arrêté d’urgence après l’automne 2021.","en":"The purpose of this notice is to advise stakeholders that Health Canada is proposing to: maintain the flexibilities and regulatory oversight provided by the Interim order respecting clinical trials for medical devices and drugs relating to COVID-19 until at least the fall of 2021, and bring forward regulatory amendments that would allow the flexibilities under the Interim Order to continue after the fall of 2021."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"ff78be56-8151-44bb-80e6-6b2ca91f4287","metadata_created":"2021-07-27T13:51:48.189927","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-07-27T13:51:48.189934","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-07-27","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["COVID-19","pandémie","prévisibilité","surveillance réglementaire","essais cliniques COVID-19","essais cliniques","dispositifs médicaux et médicaments","avis aux parties prenantes","arrêté d'urgence","modifications réglementaires"],"en":["COVID-19","pandemic","predictability","regulatory oversight","COVID-19 clinical trials","clinical trials","medical devices and drugs","notice to stakeholders","Interim Order","regulatory amendments"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Garantir la prévisibilité des essais cliniques relatifs à la COVID-19 et proposition concernant la conservation des registres d’essais cliniques : Avis aux intervenants","en":"Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"ff78be56-8151-44bb-80e6-6b2ca91f4287","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"060841b1-7609-4281-8cae-560a0829b616","related_relationship":"","name_translated":{"fr":"Garantir la prévisibilité des essais cliniques relatifs à la COVID-19 et proposition concernant la conservation des registres d’essais cliniques : Avis aux intervenants","en":"Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders","language":["en"],"created":"2021-07-27T13:51:48.270745","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/conducting-clinical-trial/predictability-proposal-records-retention-notice.html","last_modified":null,"position":0,"revision_id":"1a2c54c7-b19a-4947-8a17-11d796ab477f","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"ff78be56-8151-44bb-80e6-6b2ca91f4287","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"2ac87639-9709-4f69-8b27-193e5eab6ac6","related_relationship":"","name_translated":{"fr":"Garantir la prévisibilité des essais cliniques relatifs à la COVID-19 et proposition concernant la conservation des registres d’essais cliniques : Avis aux intervenants","en":"Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders","language":["fr"],"created":"2021-07-27T13:51:48.270750","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/liste-essais-cliniques-autorise/previsibilite-proposition-conservation-registres-avis.html","last_modified":null,"position":1,"revision_id":"1a2c54c7-b19a-4947-8a17-11d796ab477f","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2020-12-10 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"ff78be56-8151-44bb-80e6-6b2ca91f4287","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The purpose of this notice is to advise stakeholders that Health Canada is proposing to: maintain the flexibilities and regulatory oversight provided by the Interim order respecting clinical trials for medical devices and drugs relating to COVID-19 until at least the fall of 2021, and bring forward regulatory amendments that would allow the flexibilities under the Interim Order to continue after the fall of 2021.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders","revision_id":"1a2c54c7-b19a-4947-8a17-11d796ab477f"}